APA

Kim K. I., Sasase N., Taniguchi M., Mita K., Kinoshita K., Togitani T., Shikata M., Kimura N., Izawa S., Ohtani A., Nakao K., Muramoto Y., Kim S. R., Nabeshima S., Ishii F., Tanaka K. & Hayashi Y. (20051014). Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. : International journal of clinical pharmacology research.

Chicago

Kim K I, Sasase N, Taniguchi M, Mita K, Kinoshita K, Togitani T, Shikata M, Kimura N, Izawa S, Ohtani A, Nakao K, Muramoto Y, Kim S R, Nabeshima S, Ishii F, Tanaka K and Hayashi Y. 20051014. Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. : International journal of clinical pharmacology research.

Harvard

Kim K. I., Sasase N., Taniguchi M., Mita K., Kinoshita K., Togitani T., Shikata M., Kimura N., Izawa S., Ohtani A., Nakao K., Muramoto Y., Kim S. R., Nabeshima S., Ishii F., Tanaka K. and Hayashi Y. (20051014). Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. : International journal of clinical pharmacology research.

MLA

Kim K I, Sasase N, Taniguchi M, Mita K, Kinoshita K, Togitani T, Shikata M, Kimura N, Izawa S, Ohtani A, Nakao K, Muramoto Y, Kim S R, Nabeshima S, Ishii F, Tanaka K and Hayashi Y. Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. : International journal of clinical pharmacology research. 20051014.